Form 4 for CDNA CareDx, Inc.
Accepted 2026-06-30 17:29:07 ET · period of report 2026-06-04 · accession 0001781127-26-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-06-30 17:29 | 2026-06-04+ | CDNA | Hanna John Walter JR | Pres, CEO, Dir | M - OptEx | $8.20 | +70.0K | 701.9K | +11% | +$574.0K |
| DMT | 2026-06-30 17:29 | 2026-06-26+ | CDNA | Hanna John Walter JR | Pres, CEO, Dir | S - Sale+OE | $29.24 | -40.0K | 662.0K | -6% | -$1.17M |
| DMT | 2026-06-30 17:29 | 2026-06-04+ | CDNA | Hanna John Walter JR | Pres, CEO, Dir | M - OptEx | $0.00 | -70.0K | 630.7K | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-04 | M | A | 706 | $8.20 | 632,665 | D | — | — | |
| 2 | Common | Common Stock | 2026-06-11 | M | A | 13,618 | $8.20 | 646,283 | D | — | — | |
| 3 | Common | Common Stock | 2026-06-15 | M | A | 15,676 | $8.20 | 661,959 | D | — | — | |
| 4 | Common | Common Stock | 2026-06-26 | M | A | 100 | $8.20 | 662,059 | D | — | — | |
| 5 | Common | Common Stock | 2026-06-26 | S | D | 100 | $29.00 | 661,959 | D | — | — | (F1) The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025. |
| 6 | Common | Common Stock | 2026-06-29 | M | A | 39,900 | $8.20 | 701,859 | D | — | — | |
| 7 | Common | Common Stock | 2026-06-29 | S | D | 39,900 | $29.24 | 661,959 | D | — | — | (F1) The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025. (F2) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.58 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 8 | Derivative | Employee Stock Option (right to buy) | 2026-06-04 | M | D | 706 | $0.00 | 700,000 | D | $8.20 · — to 2034-04-14 | 706 Common Stock | (F3) 1/4th of the shares subject to the option shall vest on April 15, 2025 and 1/48th of the shares subject to the option shall vest monthly thereafter. |
| 9 | Derivative | Employee Stock Option (right to buy) | 2026-06-11 | M | D | 13,618 | $0.00 | 686,382 | D | $8.20 · — to 2034-04-14 | 13,618 Common Stock | (F3) 1/4th of the shares subject to the option shall vest on April 15, 2025 and 1/48th of the shares subject to the option shall vest monthly thereafter. |
| 10 | Derivative | Employee Stock Option (right to buy) | 2026-06-15 | M | D | 15,676 | $0.00 | 670,706 | D | $8.20 · — to 2034-04-14 | 15,676 Common Stock | (F3) 1/4th of the shares subject to the option shall vest on April 15, 2025 and 1/48th of the shares subject to the option shall vest monthly thereafter. |
| 11 | Derivative | Employee Stock Option (right to buy) | 2026-06-26 | M | D | 100 | $0.00 | 670,606 | D | $8.20 · — to 2034-04-14 | 100 Common Stock | (F3) 1/4th of the shares subject to the option shall vest on April 15, 2025 and 1/48th of the shares subject to the option shall vest monthly thereafter. |
| 12 | Derivative | Employee Stock Option (right to buy) | 2026-06-29 | M | D | 39,900 | $0.00 | 630,706 | D | $8.20 · — to 2034-04-14 | 39,900 Common Stock | (F3) 1/4th of the shares subject to the option shall vest on April 15, 2025 and 1/48th of the shares subject to the option shall vest monthly thereafter. |